Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|February 6, 2017
6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitroAbdullah Yalcin, Tugba H Solakoglu, Selahattin C Ozcan, et al.European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Open-label, phase II study of talimogene laherparepvec plus pembrolizumab for the treatment of advanced melanoma that progressed on prior anti-PD-1 therapy: MASTERKEY-115Caroline Robert, Brian Gastman, Helen Gogas, et al.Current Oncology (Toronto, Ont.)|July 28, 2023
Plasma Thermogram Parameters Differentiate Status and Overall Survival of Melanoma PatientsTaylor Q Nguyen, Gabriela Schneider, Alagammai Kaliappan, et al.Ebiomedicine|August 15, 2019
Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaRobert H I Andtbacka, Thomas Amatruda, John Nemunaitis, et al.Biochimica Et Biophysica Acta. General Subjects|April 30, 2018
Thermal liquid biopsy for monitoring melanoma patients under surveillance during treatment: A pilot studyAdrian Velazquez-Campoy, Sonia Vega, Oscar Sanchez-Gracia, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b StudyKevin J Harrington, Anthony Kong, Nicolas Mach, et al.Science Advances|June 30, 2023
Monocytic MDSCs exhibit superior immune suppression via adenosine and depletion of adenosine improves efficacy of immunotherapyOmar S Sarkar, Howard Donninger, Numan Al Rayyan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Single-Cell Immune Mapping of Melanoma Sentinel Lymph Nodes Reveals an Actionable Immunotolerant MicroenvironmentKavitha Yaddanapudi, Bryce F Stamp, Priyanka B Subrahmanyam, et al.Molecular and Cellular Biochemistry|May 17, 2020
PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cellsSelahattin C Ozcan, Aybike Sarioglu, Tugba H Altunok, et al.Journal for Immunotherapy of Cancer|May 4, 2023
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trialJason A Chesney, Igor Puzanov, Frances A Collichio, et al.Pageof 3